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Objective: To apply lectin afﬁnity chromatography and glycoproteomics-basedLC-MS/MS
to preliminarily investigate the possible potential plasma biomarkers ofOpisthorchis viverrini
(OV)-associated CCA in OV/dimethylnitrosamine (DMN)-induced CCA hamster model.
Methods: Nine Syrian hamsters were divided into 3 groups as follows (n = 3 each):
normal (healthy control group); OV group; and OV/DMN group (CCA group). Pooled
plasma samples collected from animals in each group at the 6th month post-infection with
OV metacercarae were subjected to glycoproteomics analysis. Glycoproteins in the
pooled sample from each group were initially isolated by concanavalin A (ConA)-based
afﬁnity chromatography. The expression of glycoproteins isolated by both enrichment
methods were determined using LC-MS/MS.
Results: Among the 24 ConA-binding glycoproteins isolated, two proteins, N-myc
downstream regulated gene 1 (NDRG1) and fetuin-B (FETUB) were found up-regulated
only in the samples from the OV and control groups, but not in the OV/DMN (CCA)
groups. On the other hand, one protein, i.e., NSFL1 cofactor p47 isoform ×3 (NSFL1C)
was found only in the samples from OV/DMN (CCA) and control groups, but not in the
OV group. The remaining 21 proteins were upregulated in the samples from all groups.
Conclusions: NDRG1, FETUB and NSFL1C glycoproteins isolated by ConA-based
afﬁnity chromatography could be potential biomarkers for CCA. Plasma samples with
negative for NDRG1 and FETUB proteins but positive for NSFL1C are likely to be OV-
associated CCA. Nevertheless, this conclusion remains to be conﬁrmed whether this
battery test can discriminate OV-associated CCA from other risk factors.1. Introduction
Cholangiocarcinoma (CCA) is a devastating cancer with an
incidence and mortality progressively increasing worldwide[1]. In Thailand, the high incidence rate is reported in the
northeastern region, where is the high prevalence of
Opisthorchis viverrini (OV) infection [2–4]. The risk factor
of CCA in this region is the consumption of improperly
cooked and fermented fresh water cyprinoid ﬁsh call “Pla-
ra”, which contains the OV and the pre-carcinogen nitrosa-
mine [5]. At present, the diagnosis of CCA is based on clinical
ﬁndings with radiological investigations, biochemical
measurements, and endoscopic brushing [6,7]. Current
imaging techniques including ultrasonography, computedrticle under the CC BY-NC-ND license (http://
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not efﬁcient to reveal this lesion since the tumor typically
grows along the bile duct without protruding outward as a
forming mass. Sensitivity and speciﬁcity of laboratory
assessments are often not adequate. CCA has been
characterized as highly chemoresistant. Currently, there is no
effective chemotherapeutics; the only curative treatment is
surgical resection. Nevertheless, it is applicable and effective
only when CCA is diagnosed at an early stage.
Postoperative 5-year survival rate is very low, with a recur-
rence rate of 60% and a median disease-free survival of 26
months [8]. Treatment with radiotherapy and chemotherapy
also carries a poor overall survival rate [9]. Effective early
diagnostic, prognostic, and therapeutic biomarkers are
required to improve the prognosis and prolong survival rates
in CCA patients. Identiﬁcation of new tumor markers in the
plasma/serum would therefore, be beneﬁcial in the clinical
management of this disease.
The aim of the study was to apply lectin afﬁnity chroma-
tography and glycoproteomics-based LC-MS/MS to prelimi-
narily investigate the possible potential plasma biomarkers of
Opisthorchis viverrini (OV)-associated CCA in OV/dimethyl-
nitrosamine (DMN)-induced CCA hamster model.
2. Materials and methods
2.1. Preparation of parasite
Naturally infected fresh water cyprinoid ﬁsh were captured
from a water reservoir in an endemic area of opisthorchiasis.
Fish were minced and digested with pepsin-HCl, then incubated
in a shaking water bath at 37 C for 1 h. The digested ﬁshes were
ﬁltered through sieves (pore sizes 1 000, 425 and 106 mm,
respectively). The OV metacercariae sediments were isolated
and examined under a stereomicroscope [10,11].
2.2. Preparation of dimethylnitrosamine
Dimethylnitrosamine (DMN) was purchased from Wako Pure
Chemical Industries, Ltd. (Osaka, JPN). DMN was diluted in
distilled water under biohazard cabinet to make a 12.5 ppm ﬁnal
concentration. The solution was stored in a dark container until
use. Diluted DMN was administered to hamster every day for 2
months in order to induce cholangiocarcinogenesis.
2.3. Animals and experimental design
Approval of the study protocol was obtained from the Ethics
Committee for Research in Animals, Thammasat University,
Thailand. Randomly nine bred female golden hamsters, (6–8
weeks of age, supplied by the Animals Care Unit, Faculty of
Medicine, KhonKaen University) were allocated into three
groups (n = 3 each) as follows: Control group: hamsters were fed
with normal saline (200 mL) at 1st month post-infection, OV
group: hamsters were fed with 50 OV metacercaria in normal
saline (200 mL) (0 month), OV/DMN (CCA) group: hamsters
were fed daily with 50 OV metacercaria (0 month), together with
DMN in normal saline (200 mL) daily for 2 months (from 1st to
2nd months post-infection) [12].2.4. Blood specimen collection and histopathological
examination
The hamsters of each group will be sacriﬁced under deep
anesthesia, and blood samples were collected into ethylenedi-
amine tetra-acetate (EDTA) plastic tubes, from the hearts and the
livers will be removed of each hamster in all groups at 6th
months post-infection. Pooled plasma sample from each group
was separated through centrifugation at 3 000× g for 10 min
(4 C) and stored at −80 C until analysis. The livers were
examined for gross pathology and histopathology. Then, the
livers were ﬁxed in 10% buffer formalin, serially sliced in a 4–
5 mm thickness, embed in parafﬁn. Sections were cut as 4 mm
thickness and stained with hematoxylin-eosin [13].
2.5. Isolation of glycoprotein from pooled plasma
samples using concanavalin A (ConA)-based afﬁnity
chromatography
Isolation of glycoproteins in the pooled plasma sample
collected at 6th months post-infection in each group was per-
formed using ConA lectin resin kit (Thermo Scientiﬁc Inc) ac-
cording to the manufacturer's recommendations. In brief, the
ConA lectin resin column was prepared using 200 mL of 50%
resin. The column was initially equilibrated with 600 mL of the
binding buffer. The pooled plasma sample (800 mL) was loaded
onto the equilibrated column. After incubating for 10 min at
room temperature (25 C) with end-over-end mixing using a
rotator, the column was centrifuged for 1 min at 1 000 × g and
the ﬂow-through was discarded. The unbound proteins in the
column were removed by washing four times with the binding
buffer. The glycoproteins bound ConA were eluted twice with
200 mL of elution buffer at room temperature for 5 min with end-
over-end mixing using a rotator. The column was centrifuged for
1 min at 1 000 × g and the eluate was collected.
2.6. LC-MS/MS analysis
2.6.1. Peptides preparation for LC-MS/MS analysis
The eluted glycosylated protein fractions from the pooled
plasma sample of each group were directly applied onto a
ZebaTM Spin Desalting columns (Thermo Scientiﬁc Inc) and
protein concentration in each desalted fraction determined by
Lowry assay using BSA as a standard protein. The Sub-10 kDa
protein fraction (>2 mg) was reduced and alkylated with
dithiothreitol (DTT) and Iodoacetamide, respectively. The
sample was digested with trypsin and kept at −80 C for further
mass spectrometric analysis.
2.6.2. HCTUltra LC-MS analysis
Peptides in the prepared samples were analyzed using an
HCTultra PTM Discovery System (Bruker Daltonics Ltd., Ger-
many) coupled to anUltiMate 3000LCSystem (Dionex Ltd., UK).
Peptides were separated on a nanocolumn (PepSwift monolithic
column 100 mm i.d. × 50 mm). Eluent A and B consisted of 0.1%
formic acid and 80% acetonitrile in water containing 0.1% formic
acid. Peptide separation was achieved with a linear gradient from
10% to 70% eluate B for 13 min at a ﬂow rate of 300 nL/min,
followed by a regeneration step at 90% eluate B and an
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were acquired in data-dependent AutoMS mode with a scan range
of 300–1 500 m/z, 3 averages, and up to 5 precursor ions selected
from the MS scan 50–3 000 m/z.
2.6.3. Protein quantitation and identiﬁcation
DeCyder MS Differential Analysis software (DeCyder MS,
GE Healthcare) was used for quantitation of proteins in the
samples. Acquired LC-MS raw data were converted and the
PepDetect module was used for automated peptide detection,
charge state assignment, and quantitation, based on the peptide
ions signal intensities in MS mode. The analyzed MS/MS data
from DeCyder MS were submitted for a database search using
the Mascot software. The data were as searched against the
NCBI database for protein identiﬁcation. Database interrogation;
taxonomy (Homo sapiens); enzyme (trypsin); variable modiﬁ-
cations (carbamidomethyl, oxidation of methionine residues);
mass values (monoisotopic); protein mass (unrestricted); peptide
mass tolerance (1.2 Da); fragment mass tolerance (±0.6 Da),
peptide charge state (1+, 2+ and 3+) and max missed cleavages.
The maximum value of each group was used to determine the
presence or absence of each identiﬁed protein. Data normaliza-
tion and quantiﬁcation of the changes in protein abundance
between the control and OV or OV/DMN treated samples were
performed and visualized using MultiExperiment Viewer (Mev)
software version 4.6.1. Brieﬂy, peptide intensities from the LC-
MS analyses were transformed and normalized using a mean
central tendency procedure. Statistical analysis for comparison
of the protein contents in the plasma samples from the three
groups was performed using Analysis of Variance (ANOVA) at
the statistical signiﬁcance level of P < 0.05. Gene ontology
annotation including biological process, cellular component and
molecular function were performed using Gocat (http://eagl.
unige.ch/GOCat/). Protein-chemical interactions were analyzed
according to STITCH 4.0 database (http://stitch.embl.de/).Figure 1. Representative gross and histopathological examination of the livers3. Results
3.1. Gross pathology and histopathology of liver of OV/
DMN-induced CCA in hamsters
Based on gross liver autopsy appearance, hamsters infected
with Opisthorchis viverrini together with the DMN administra-
tion (OV/DMN: CCA group) showed opaque common hepatic
bile ducts. The mass forming lesions were detected from gross
observation of the liver's surface. In the OV-treated group, the
gallbladder and common bile ducts were slightly enlarged and
opaque, with wall thickening in accordance with the duration
time of infection. In the control group, liver appeared normal
with a red color and smooth surface. Results obtained from
histopathological examination in all groups were found to be in
good correlation between gross autopsy and histopathology
(Figure 1).3.2. Identiﬁcation of ConA-binding glycoproteins by LC-
MS/MS
After enrichment, a total of 24 glycoproteins were identiﬁed
using LC-MS/MS in all the control, OV and OV/DMN (CCA)
groups (Table 1). A two-way hierarchical clustering analysis
(heatmap analysis) indicates that 24 proteins were differentially
expressed in the pooled plasma samples of the three groups
(Figure 2). Figure 3 shows the Venn diagram of 24 glycopro-
teins that were differentially expressed only in the plasma
sample from each group (0 glycoprotein in all groups) and
those with overlapping existence in either the samples from
both the CCA and control groups (1 glycoprotein), the OV/
DMN (CCA) and OV group (no glycoprotein), the OV and
control group (2 proteins), as well as those which were up-
regulated in all groups (21 glycoproteins). Two glycoproteinsfrom (A) OV/DMN (CCA), (B) OV, and (C) control groups.
Table 1
List of glycoproteins isolated by ConA-based afﬁnity chromatography.
Database ID no. Protein name Protein ID score Peptides
gi|524938471 Fetuin-B 36.27 LVVLPFPGK
gi|537118064 Protein NDRG1 18.65 SRSHTSEDAR
gi|354467899 Fatty aldehyde dehydrogenase-like 11.69 CXSRPLR
gi|524968551 Alpha-2-macroglobulin-like 53.27 SIGLNVFTNSK
gi|524968948 Phosphatidylinositol 4-kinase beta isoform X3 11.92 MAIGK
gi|537225446 Transcription factor HIVEP3 7.36 KASSFPPMDR
gi|537274398 Glutathione S-transferase theta-1-like protein 18.43 DMPPLMDPTLK
gi|524942047 NSFL1 cofactor p47 isoform ×3 17.97 KSPNELVDDLFKGAK
gi|537200449 Tripartite motif-containing protein 30 9.35 MASAFMANVK
gi|537237353 Glucocorticoid modulatory element-binding protein 1 36.34 EIEELLR
gi|537168917 Ig lambda chain V-I region BL2-like protein 34.22 QITVSWLR
gi|354495235 Zinc ﬁnger protein 394-like 5.27 TDSMK
gi|537257512 TSC22 domain family protein 2, partial 8.68 TEDVSSEIFDVSR
gi|537169691 Protein Daple 35.72 KAGSLNLQIEK
gi|537168406 Serpin B11 23.58 GKSAEQMEK
gi|537226277 Glycoside hydrolase, family 31 containing protein 8.51 HVDPEALQK
gi|524955568 V-set and transmembrane domain-containing protein 4 13.79 KDSLLAVR
gi|537260058 Fibrinogen gamma chain-like protein 52.84 TSTADYAMFR
gi|524959813 Ceruloplasmin 19.90 TESSTVVPTLPGETR
gi|537200957 ATP-binding cassette sub-family E member 1 11.40 KMCMYK
gi|537167905 Zinc ﬁnger Ran-binding domain-containing protein 3 9.18 AGAVK
gi|524969534 Ubiquitin carboxyl-terminal hydrolase 7 28.67 QVSQNGGQPL
gi|537091186 Hypothetical protein H671_21496, partial 20.55 YNYKGQR
gi|344249997 Mitochondrial import inner membrane translocase subunit Tim17-B 20.55 GKEDPWNSITSGALTGAVLAAR
Figure 2. Hierarchical clustering analysis (heatmap analysis) of glycoproteins isolated from the pooled plasma samples of the control, OV, and OV/DMN
(CCA) groups, by ConA-based afﬁnity chromatography. The red colors represent up-regulated proteins and the green colors represent down-regulated
proteins.
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Fetuin-B (FETUB) and Protein NDRG1 (NDRG1). One pro-
tein, NSFL1 cofactor p47 isoform ×3 (NSFL1C), was found
up-regulated only in the samples from the CCA and control.
The possible functional interactions and associations between
the three glycoproteins with differential expression in plasmasamples from the three groups and chemical compounds
available in the published articles database were predicted us-
ing STITCH 4 software based on the following analysis pa-
rameters: species (Homo sapiens); medium conﬁdence score
(0.0400); and active prediction methods (all and no more than
10). The interactions between NDRG1, FetuB, NSFL1C and
Figure 3. Venn diagrams showing 24 ConA-binding glycoproteins in the
control, OV, and OV/DMN (CCA) groups. The numbers indicate glyco-
proteins which were present in each group, two of the three groups, and all
of the three groups.
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Figure 4. Gemcitabine and cisplatin were predicted to directly
interact with EGFR, and TP53, but indirectly interact with
MYC and NDRG1.Figure 4. The networks of protein-chemical interactions of the three selected g
rectangle) in plasma samples from the control, OV, and OV/DMN (CCA) group
predicted using STITCH 4 software. The interactions are shown in diffe
NSFL1C = NSFL1 cofactor p47 isoform ×3).4. Discussion
The OV/DMN-induced CCA hamster model was used as an
animal model for CCA in the present study as it closely mimics
the pathogenesis of human CCA [14–20] OV infection is
proposed as a promotor and the carcinogen DMN as an
initiator of CCA carcinogenesis [14]. At the 6th month post-
infection with OV metacercarae, tumor masses were found to
develop in the livers of all the OV/DMN-induced CCA ham-
sters, but not in the control and OV groups. In the previous
study, CCA tumor was detected as early as three months after
induction [21]. Conﬁrmation of CCA by histopathological
examination is underway.
The isolated glycoproteins enriched by both ConA and WGA
afﬁnity chromatography were found to be differentially
expressed in the pool plasma samples from the OV, OV/DMN
(CCA) and control groups. Among the 24 ConA-binding gly-
coproteins isolated, two proteins, N-myc downstream regulated
gene 1 (NDRG1) and fetuin-B (FETUB) were found up-
regulated only in the samples from the OV and control
groups, but not in the OV/DMN (CCA) groups. On the other
hand, one protein, i.e., NSFL1 cofactor p47 isoform ×3
(NSFL1C) was found only in the samples from OV/DMN
(CCA) and control groups, but not in the OV group. The
remaining 21 proteins were upregulated in the samples from all
groups.
NDRG1 is a cytoplasmic protein involved in stress re-
sponses, hormone responses, cell growth, and differentiation.
The encoded protein is necessary for p53-mediated caspase
activation and apoptosis [22]. The role of NDRG1 is
controversial for various cancers. NDRG1 expression was
found to be associated with good prognosis in colon cancer,
and pancreatic cancer. On the other hand, its expression waslycoproteins isolated by ConA-based afﬁnity chromatography (red rounded
s, and anticancer drugs; gemcitabine and cisplatin (green rounded rectangle)
rent color lines. (FETUB = Fetuin-B, NDRG1 = Protein NDRG1, and
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lung cancer, hepatocellular carcinoma, and gallbladder cancer.
The discordant correlation between NDRG1 and disease prog-
nosis has been reported for many types of cancer [23]. In our
study, NDRG1 was found to be down-regulated in plasma
sample of the CCA group.
Results obtained from STITCH 4 analysis (Figure 4) pre-
dicted the interaction of NDRG1 and anticancer drugs gemci-
tabine and cisplatin. Gemcitabine and cisplatin activate the
expression of TP53 that improved expression of NDRG1.
Currently chemotherapy combining gemcitabine and cisplatin is
the recommended ﬁrst-line treatment regimen for advanced
biliary tract cancer. The combination of gemcitabine and
cisplatin has been shown to improve overall survival and
progression-free survival by 30% over gemcitabine alone [24].
The expression of drugs targeting on NDRG1 may provide
novel therapeutic approach for CCA.
Taken together, results suggest that NDRG1, FETUB and
NSFL1C glycoproteins isolated by ConA-based afﬁnity chro-
matography could be potential biomarkers for CCA. Plasma
samples with positive expression of NSFL1C, with no expres-
sion of NDRG1 and FETUB are likely suggestive of OV-
associated CCA. These potential biomarkers may be exploited
as tools for diagnosis, monitoring of disease prognosis and
progress of CCA. This conclusion remains to be conﬁrmed
whether the battery test based on these biomarkers can
discriminate OV-associated CCA from other risk factors. One
limitation of the current study is that the biomarker analysis was
performed using plasma samples from animals, not humans.
Therefore, results may not totally represent the glycoprotein
biomarkers in humans. Nevertheless, the advantage of using this
animal model is that, it allows for possibility to investigate
biomarkers for early diagnosis of CCA as it is not possible to
obtain plasma samples from patients with early diagnosis.
Further validation of the assay performance of this battery test in
the human CCA is essential before application of the test as a
diagnostic tool for CCA and OV infection.
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